Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial.
de Wijkerslooth TR, de Haan MC, Stoop EM, Deutekom M, Fockens P, Bossuyt PM, Thomeer M, van Ballegooijen M, Essink-Bot ML, van Leerdam ME, Kuipers EJ, Dekker E, Stoker J. de Wijkerslooth TR, et al. Among authors: van leerdam me, van ballegooijen m. BMC Gastroenterol. 2010 May 19;10:47. doi: 10.1186/1471-230X-10-47. BMC Gastroenterol. 2010. PMID: 20482825 Free PMC article. Clinical Trial.
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.
Stoop EM, de Haan MC, de Wijkerslooth TR, Bossuyt PM, van Ballegooijen M, Nio CY, van de Vijver MJ, Biermann K, Thomeer M, van Leerdam ME, Fockens P, Stoker J, Kuipers EJ, Dekker E. Stoop EM, et al. Among authors: van leerdam me, van de vijver mj, van ballegooijen m. Lancet Oncol. 2012 Jan;13(1):55-64. doi: 10.1016/S1470-2045(11)70283-2. Epub 2011 Nov 15. Lancet Oncol. 2012. PMID: 22088831 Clinical Trial.
Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.
van Roon AH, Hol L, van Vuuren AJ, Francke J, Ouwendijk M, Heijens A, Nagtzaam N, Reijerink JC, van der Togt AC, van Ballegooijen M, Kuipers EJ, van Leerdam ME. van Roon AH, et al. Among authors: van der togt ac, van vuuren aj, van leerdam me, van ballegooijen m. Am J Gastroenterol. 2012 Jan;107(1):99-107. doi: 10.1038/ajg.2011.396. Epub 2011 Nov 22. Am J Gastroenterol. 2012. PMID: 22108450
Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.
Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, Kuipers EJ, Fockens P, Kraaijenhagen RA, Bossuyt PM. Stegeman I, et al. Among authors: van leerdam me, van ballegooijen m. Cancer Epidemiol. 2013 Jun;37(3):278-83. doi: 10.1016/j.canep.2013.02.004. Epub 2013 Mar 9. Cancer Epidemiol. 2013. PMID: 23491770
Attendance and yield over three rounds of population-based fecal immunochemical test screening.
Kapidzic A, Grobbee EJ, Hol L, van Roon AH, van Vuuren AJ, Spijker W, Izelaar K, van Ballegooijen M, Kuipers EJ, van Leerdam ME. Kapidzic A, et al. Among authors: van roon ah, van vuuren aj, van leerdam me, van ballegooijen m. Am J Gastroenterol. 2014 Aug;109(8):1257-64. doi: 10.1038/ajg.2014.168. Epub 2014 Jul 1. Am J Gastroenterol. 2014. PMID: 24980879
Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
Toes-Zoutendijk E, van Leerdam ME, Dekker E, van Hees F, Penning C, Nagtegaal I, van der Meulen MP, van Vuuren AJ, Kuipers EJ, Bonfrer JMG, Biermann K, Thomeer MGJ, van Veldhuizen H, Kroep S, van Ballegooijen M, Meijer GA, de Koning HJ, Spaander MCW, Lansdorp-Vogelaar I; Dutch National Colorectal Cancer Screening Working Group. Toes-Zoutendijk E, et al. Among authors: van der meulen mp, van veldhuizen h, van vuuren aj, van leerdam me, van hees f, van ballegooijen m. Gastroenterology. 2017 Mar;152(4):767-775.e2. doi: 10.1053/j.gastro.2016.11.022. Epub 2016 Nov 24. Gastroenterology. 2017. PMID: 27890769
Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.
Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I; Dutch National Colorectal Cancer Screening Working Group. Toes-Zoutendijk E, et al. Among authors: van veldhuizen h, van vuuren aj, van leerdam me, van kemenade fj, van ballegooijen m. Clin Gastroenterol Hepatol. 2020 Jun;18(7):1493-1500. doi: 10.1016/j.cgh.2019.08.021. Epub 2019 Aug 20. Clin Gastroenterol Hepatol. 2020. PMID: 31442598 Free article.
192 results